Prevalence and characteristics of hepatitis C virus coinfection in a human immunodefidency virus clinical trials group: The Terry Beirn Community Programs for Clinical Research on AIDS

Ellen M. Tedaldi, Katherine Huppler Hullsiek, Carlos D. Malvestutto, Roberto C. Arduino, Evelyn J. Fisher, Paul J. Gaglio, Elizabeth R. Jenny-Avital, Joseph P. McGowan, George Perez

Research output: Contribution to journalArticle

47 Scopus citations

Abstract

The baseline prevalence of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection among 2705 patients enrolled in HIV clinical trials in the Community Programs for Clinical Research on AIDS (CPCRA) was 16.6%. For men, multivariate logistic regression showed that the baseline prevalence of HIV-HCV coinfection was positively associated with history of injection drug use, older age, antiretroviral therapy naive status, African American or Latino ethnicity, and no history of having sex with men. No association was found with baseline CD4+ cell count or HIV RNA level. The prevalence of HCV coinfection in a diverse HIV clinical trials cohort provides additional information about risk behaviors and demographic factors that can be used in the analysis of clinical and virologic outcomes.

Original languageEnglish (US)
Pages (from-to)1313-1317
Number of pages5
JournalClinical Infectious Diseases
Volume36
Issue number10
DOIs
StatePublished - May 15 2003

    Fingerprint

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Tedaldi, E. M., Huppler Hullsiek, K., Malvestutto, C. D., Arduino, R. C., Fisher, E. J., Gaglio, P. J., Jenny-Avital, E. R., McGowan, J. P., & Perez, G. (2003). Prevalence and characteristics of hepatitis C virus coinfection in a human immunodefidency virus clinical trials group: The Terry Beirn Community Programs for Clinical Research on AIDS. Clinical Infectious Diseases, 36(10), 1313-1317. https://doi.org/10.1086/374841